
1. skin therapy lett. 2006 jul-aug;11(6):1-3.

vaccines prevention human papillomavirus infections.

speck lm(1), tyring sk.

author information: 
(1)university texas medical branch, galveston, usa.

human papillomavirus (hpv) infection known cause almost cases of
cervical cancer. understanding hpv genome allowed development
of two prophylactic vaccines capable protecting persistent hpv
infection cervical intraepithelial neoplasia (cin) 100% efficacy in
fully vaccinated women. vaccines, manufactured merck (gardasil, 
approved us fda june, 2006) glaxosmithkline (cervarix, will
be submitted us fda approval end 2006), target hpv types 16
and 18, together account 70% cervical cancer. merck vaccine also
targets hpv 6 11, covering =90% genital warts. vaccines highly
immunogenic excellent safety profile. hpv vaccines promise offer
an exciting contribution healthcare cancer prevention. however, many
questions remain concerning vaccinate, duration protection, cost,
public acceptance, potential worldwide distribution.


pmid: 16912836  [indexed medline]

